American Century Companies’s Janux Therapeutics JANX Stock Holding History

American Century Companies's JANX Position: Q2 2026 in Review

American Century Companies increased its Janux Therapeutics (JANX) stake by 54% in Q2 2026, buying an estimated $236K and bringing the position to 46,476 shares worth $714K. The position accounts for ﹤0.01% of the portfolio, ranked #2506.

American Century Companies first reported a position in JANX in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.02M in Q1 2024. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

• American Century Companies held 46,476 shares of Janux Therapeutics worth $714K as of Q2 2026.
• American Century Companies bought 16,261 Janux Therapeutics shares in Q2 2026, an estimated $236K.
• Janux Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2506 holding.
• American Century Companies first reported a position in Janux Therapeutics in Q4 2023 and has held it in 8 quarters since.
• American Century Companies's Janux Therapeutics position peaked at $1.02M in Q1 2024.
• 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.